<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39189008</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2352-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>54</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of cardiology. Heart &amp; vasculature</Title><ISOAbbreviation>Int J Cardiol Heart Vasc</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular disease and covid-19: A systematic review.</ArticleTitle><Pagination><StartPage>101482</StartPage><MedlinePgn>101482</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101482</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcha.2024.101482</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Cardiovascular complications of COVID-19 are numerous and aspects of this phenomenon are not well known. The main objective of this manuscript is a systematic review of the acute and chronic cardiovascular complications secondary to COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systematic review of the literature through Medline via PubMed was conducted (2020-2024).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There is a plethora of effects of COVID-19 on the heart in the acute setting. Here we discuss pathophysiology, myocardial infarctions, heart failure, Takotsubo Cardiomyopathy, myocardial injury, myocarditis and arrhythmias that are caused by COVID-19. Additionally, these cardiovascular injuries can linger and may be an underlying cause of some Long COVID symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Cardiovascular complications of COVID-19 are numerous and life-threatening. Long COVID can affect cardiovascular health. Microclotting induced by SARS-CoV-2 infection could be a therapeutic target for some aspects of Long Covid.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krishna</LastName><ForeName>B A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metaxaki</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sithole</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Cambridge University, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Land&#xed;n</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Cl&#xed;nico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hospital Cl&#xed;nico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salinas-Botr&#xe1;n</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Hospital Cl&#xed;nico San Carlos, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Cardiol Heart Vasc</MedlineTA><NlmUniqueID>101649525</NlmUniqueID><ISSNLinking>2352-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Long COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39189008</ArticleId><ArticleId IdType="pmc">PMC11345335</ArticleId><ArticleId IdType="doi">10.1016/j.ijcha.2024.101482</ArticleId><ArticleId IdType="pii">S2352-9067(24)00148-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafi A.M., Shaikh S.A., Shirke M.M., Iddawela S., Harky A. Cardiac manifestations in COVID-19 patients&#x2014;a systematic review. J. Card. Surg. 2020;35:1988&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404674</ArticleId><ArticleId IdType="pubmed">32652713</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal-Perez R., et al. Cardiovascular disease and COVID-19, a deadly combination: a review about direct and indirect impact of a pandemic. World J. Clin. Cases. 2022;10:9556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9516905</ArticleId><ArticleId IdType="pubmed">36186196</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia J., et al. Prognostic impact of prior heart failure in patients hospitalized with COVID-19. J. Am. Coll. Cardiol. 2020;76:2334&#x2013;2348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598769</ArticleId><ArticleId IdType="pubmed">33129663</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey J.R., et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur. J. Heart Fail. 2020;22:2205&#x2013;2215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461427</ArticleId><ArticleId IdType="pubmed">32833283</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Kapusta J. Cardiovascular Complications of COVID-19: Acute and Long-Term Impacts. Springer; 2023. pp. 379&#x2013;400.</Citation></Reference><Reference><Citation>Krishna B., Wills M., Sithole N. Long COVID: what is known and what gaps need to be addressed. Br. Med. Bull. 2023;147:6&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield B.A., Bhatt D.L., Gersh B.J. Cardiac involvement in the long-term implications of COVID-19. Nat. Rev. Cardiol. 2022;19:332&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B.A., et al. Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine. 2022;81</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;1&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B.A., et al. Spontaneous, persistent, T cell&#x2013;dependent IFN-&#x3b3; release in patients who progress to Long Covid. Sci. Adv. 2024;10:eadi9379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Selva K.J., et al. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat. Commun. 2021;12:2037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016934</ArticleId><ArticleId IdType="pubmed">33795692</ArticleId></ArticleIdList></Reference><Reference><Citation>Elseidy S.A., et al. Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS) IJC Heart Vasc. 2022;40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8958273</ArticleId><ArticleId IdType="pubmed">35355927</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni S., de Groot R., Bell S., Markus H.S. Stroke in COVID-19: a systematic review and meta-analysis. Int. J. Stroke. 2021;16:137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz M.M., et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J. Clin. Med. 2021;10:2945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B., et al. Relationship between myocardial injury during index hospitalization for SARS-CoV-2 infection and longer-term outcomes. J. Am. Heart Assoc. 2022;11:e022010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9075193</ArticleId><ArticleId IdType="pubmed">34970914</ArticleId></ArticleIdList></Reference><Reference><Citation>Laribi S., et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur. J. Heart Fail. 2012;14:234&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">22237388</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermida Ameijeiras A., et al. Anales de medicina interna. SciELO Espana. 2008;25:256&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">19295971</ArticleId></ArticleIdList></Reference><Reference><Citation>Formiga F., et al. Predictors of in-hospital mortality present at admission among patients hospitalised because of decompensated heart failure. Cardiology. 2007;108:73&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">17003545</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigorian Shamagian L., Gonzalez-Juanatey J.R., Roman A.V., Acu&#xf1;a J.M.G., Lamela A.V. The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period. Eur. Heart J. 2005;26:2251&#x2013;2258.</Citation><ArticleIdList><ArticleId IdType="pubmed">15985441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons F., et al. Mortalidad y causas de muerte en pacientes con insuficiencia cardiaca: experiencia de una unidad especializada multidisciplinaria. Rev. Esp. Cardiol. 2010;63:303&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski A., et al. Gu&#xed;a ESC 2016 sobre el diagn&#xf3;stico y tratamiento de la insuficiencia cardiaca aguda y cr&#xf3;nica. Rev. Esp. Cardiol. 2016;69</Citation></Reference><Reference><Citation>Ramos-Rincon J.-M., et al. Clinical characteristics and risk factors for mortality in very old patients hospitalized with COVID-19 in Spain. J. Gerontol.: Ser. A. 2021;76:e28&#x2013;e37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797762</ArticleId><ArticleId IdType="pubmed">33103720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromage D.I., et al. The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic. Eur. J. Heart Fail. 2020;22:978&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300902</ArticleId><ArticleId IdType="pubmed">32478951</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodilla E., et al. Association of hypertension with all-cause mortality among hospitalized patients with covid-19. J. Hypertens. 2021;39:e37.</Citation></Reference><Reference><Citation>Promislow D.E. A geroscience perspective on COVID-19 mortality. J. Gerontol.: Ser. A. 2020;75:e30&#x2013;e33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184466</ArticleId><ArticleId IdType="pubmed">32300796</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., et al. Mayo Clinic Proc. 2020;vol. 95:1138&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151468</ArticleId><ArticleId IdType="pubmed">32376101</ArticleId></ArticleIdList></Reference><Reference><Citation>K.B. vol. 95. Elsevier; 2020. Kashani; pp. 1094&#x2013;1096. (Mayo Clinic Proceedings).</Citation></Reference><Reference><Citation>Yan Q., et al. Acute kidney injury is associated with in-hospital mortality in older patients with COVID-19. J. Gerontol.: Ser. A. 2021;76:456&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454401</ArticleId><ArticleId IdType="pubmed">32766817</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores L.K., et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158:1143&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265858</ArticleId><ArticleId IdType="pubmed">32502594</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton A., et al. Evolution of 18F-FDG PET/CT findings in patients after COVID-19: an initial investigation. J. Nucl. Med. 2022;63:270&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805777</ArticleId><ArticleId IdType="pubmed">34272318</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G., et al. Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. Cardiovasc. Imag. 2021;14:2155&#x2013;2166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher A.K., et al. Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19. Nat. Commun. 2022;13:7947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9791976</ArticleId><ArticleId IdType="pubmed">36572683</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels C.J., et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6:1078&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetanov K.A., et al. Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: a prospective observational cohort study. medRxiv. 2022 2022.2002.2001.22270235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639388</ArticleId><ArticleId IdType="pubmed">36451358</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of treatment with Nirmatrelvir and the risk of post&#x2013;COVID-19 condition. JAMA Intern. Med. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Matejova G., et al. Cardiac sequelae after COVID-19: Results of a 1-year follow-up study with echocardiography and biomarkers. Front. Cardiovasc. Med. 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9810981</ArticleId><ArticleId IdType="pubmed">36620643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai C., et al. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated international task force (29 July 2020) Eur. Respir. Rev. 2020;29</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537943</ArticleId><ArticleId IdType="pubmed">33020069</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E., et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect. Dis. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106320</ArticleId><ArticleId IdType="pubmed">35576963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani R.D., Dabas N., Goldberger J.J. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17:1984&#x2013;1990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson O.J., et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect. Dis. 2022;22:1293&#x2013;1302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9225255</ArticleId><ArticleId IdType="pubmed">35753318</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay J., et al. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. BMJ. 2022;378</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9277081</ArticleId><ArticleId IdType="pubmed">35830976</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein N.P., et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021;326:1390&#x2013;1399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511971</ArticleId><ArticleId IdType="pubmed">34477808</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., et al. A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis. Am. J. Prev. Med. 2023;64:275&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510095</ArticleId><ArticleId IdType="pubmed">36266115</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B.A., Metaxaki M., Wills M.R., Sithole N. Reduced incidence of long coronavirus disease referrals to the Cambridge university teaching hospital long coronavirus disease clinic. Clin. Infect. Dis. 2023;76:738&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384550</ArticleId><ArticleId IdType="pubmed">35913432</ArticleId></ArticleIdList></Reference><Reference><Citation>P. Kuodi et al., Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv, 2022.2001.2005.22268800 (2022).</Citation></Reference><Reference><Citation>Ayoubkhani D., et al. Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study. medRxiv. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., et al. Impact of vaccination on major adverse cardiovascular events in patients with COVID-19 infection. J. Am. Coll. Cardiol. 2023;81:928&#x2013;930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9939951</ArticleId><ArticleId IdType="pubmed">36813689</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteley W.N., et al. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: a population-based cohort study of 46 million adults in England. PLoS Med. 2022;19:e1003926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863280</ArticleId><ArticleId IdType="pubmed">35192597</ArticleId></ArticleIdList></Reference><Reference><Citation>Barda N., et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N. Engl. J. Med. 2021;385:1078&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427535</ArticleId><ArticleId IdType="pubmed">34432976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.-E., Huh K., Park Y.-J., Peck K.R., Jung J. Association between vaccination and acute myocardial infarction and ischemic stroke after COVID-19 infection. JAMA. 2022;328:887&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9449799</ArticleId><ArticleId IdType="pubmed">35867050</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., et al. SARS-CoV-2 spike protein S1 induces fibrin (ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. 2021;41</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/post-acute sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 2022;21:1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., et al. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>G.J. Laubscher et al., Treatment of Long COVID symptoms with triple anticoagulant therapy, 2023.</Citation></Reference><Reference><Citation>Steenblock C., et al. Post COVID and apheresis-where are we standing? Horm. Metab. Res. 2022</Citation><ArticleIdList><ArticleId IdType="pubmed">36113501</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado J., et al. HEART rate variability biofeedback for LOng COVID dysautonomia (HEARTLOC): results of a feasibility study. Adv. Rehabil. Sci. Pract. 2024;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10826406</ArticleId><ArticleId IdType="pubmed">38298551</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb Y.N. Nirmatrelvir plus ritonavir: first approval. Drugs. 2022;82:585&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8933659</ArticleId><ArticleId IdType="pubmed">35305258</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>